Clinical Trial Update: A Study To Assess the Safety and Efficacy of JZP385 in the Treatment of Adults With Moderate to Severe Essential Tremor (ET) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of JZP385 in adults with Essential tremor has completed. The results have been posted on 2025-07-24.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Tremor

Drugs mentioned

• JZP385

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Essential Tremor | Phase 2 | Status: COMPLETED | Results posted: 2025-07-24